X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (4) 4
aged (4) 4
female (4) 4
humans (4) 4
male (4) 4
middle aged (4) 4
aged, 80 and over (3) 3
in situ hybridization, fluorescence (3) 3
index medicus (3) 3
adolescent (2) 2
chronic myelogenous leukemia (2) 2
cytogenetic abnormalities (2) 2
fluorescence (2) 2
hematology (2) 2
hemic and lymphatic diseases (2) 2
leukemia (2) 2
oncology (2) 2
philadelphia chromosome (2) 2
real-time polymerase chain reaction (2) 2
translocation, genetic (2) 2
young adult (2) 2
8p11 syndrome (1) 1
abl (1) 1
additional chromosomal abnormalities (1) 1
adolescent ; adult ; aged ; aged, 80 and over ; antineoplastic agents ; chromosome aberrations ; cytogenetic analysis ; female ; humans ; in situ hybridization, fluorescence ; leukemia, myeloid, chronic-phase ; male ; middle aged ; philadelphia chromosome ; piperazines ; prognosis ; prospective studies ; pyrimidines ; real-time polymerase chain reaction ; reverse transcriptase polymerase chain reaction ; rna, messenger ; survival rate ; young adult (1) 1
aml, mds, evi1, mecom, complex rearrangements, chromosomal abnormalities, overexpression (1) 1
amplification (1) 1
analysis (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bcr (1) 1
bcr/abl (1) 1
bcr/abl; cml; fish; philadelphia chromosome; tki; oncology (1) 1
benzamides (1) 1
cancer (1) 1
care and treatment (1) 1
cell biology (1) 1
chromosome aberrations (1) 1
chromosome aberrations - chemically induced (1) 1
chromosome banding (1) 1
chromosomes, human, pair 3 (1) 1
chromosomes, human, pair 8 - genetics (1) 1
chronic myeloid-leukemia (1) 1
cml (1) 1
cml analysis (1) 1
cytogenetic analysis (1) 1
development and progression (1) 1
dna-binding proteins - genetics (1) 1
drug therapy, combination (1) 1
european-leukemianet (1) 1
evi1 expression (1) 1
eye diseases (1) 1
fish (1) 1
fragile sites (1) 1
frontline imatinib therapy (1) 1
fusion gene transcripts (1) 1
fusion proteins, bcr-abl - antagonists & inhibitors (1) 1
fusion proteins, bcr-abl - genetics (1) 1
gene (1) 1
gene expression regulation, neoplastic (1) 1
gene rearrangement (1) 1
genetic variation (1) 1
genetics & heredity (1) 1
gimema working party (1) 1
hematologic neoplasms - genetics (1) 1
hematological malignancies (1) 1
hematology, oncology and palliative medicine (1) 1
histone acetyltransferases - genetics (1) 1
identification (1) 1
imatinib mesylate (1) 1
in-situ hybridization (1) 1
inv/t (1) 1
karyotyping (1) 1
kinase inhibitor therapy (1) 1
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (1) 1
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (1) 1
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1) 1
leukemia, myeloid, acute - genetics (1) 1
leukemia, myeloid, chronic-phase - drug therapy (1) 1
leukemia, myeloid, chronic-phase - genetics (1) 1
leukemia, myeloid, chronic-phase - mortality (1) 1
location (1) 1
mds1 and evi1 complex locus protein (1) 1
mesylate therapy (1) 1
methods (1) 1
minimal-residual-disease (1) 1
molecular response (1) 1
multiple myeloma (1) 1
myelodysplastic syndrome (1) 1
myelodysplastic syndromes - genetics (1) 1
myst3 (1) 1
patient outcomes (1) 1
pharmacogenetics (1) 1
philadelphia-chromosome (1) 1
piperazines - adverse effects (1) 1
prognosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 07/2012, Volume 120, Issue 4, pp. 761 - 767
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2080 - 2080
Abstract Background Multiple Myeloma (MM) is a biologically complex disease, whose genetic plasticity favors the coexistence of genetically heterogeneous... 
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 18, pp. 29906 - 29913
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 2054 - 2054
Abstract Background Although remarkable advances have been achieved in MM therapy, mainly thanks to the introduction of novel-agent-based regimens, the disease... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3400 - 3400
Abstract Introduction. The role of TP53 tumor-suppressor gene in mediating cellular basic tumor suppressive mechanisms is crucial: its utmost importance is... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 2042 - 2042
Abstract INTRODUCTION: Cytogenetic abnormalities (CA) are one of the major factor for risk stratification in Multiple Myeloma (MM). Approximately 50% of MM... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.